Screener
Altimmune ALT Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Altimmune’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326190-26-000040
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $1,530 | $2,717 |
| Accrued expenses and other current liabilities | 9,793 | 12,280 |
| Total current liabilities | 11,323 | 14,997 |
| Term loan, noncurrent | 34,505 | 34,287 |
| Other noncurrent liabilities | 5,815 | 5,753 |
| Total liabilities | 51,643 | 55,037 |
| Commitments and contingencies (Note 10) |
Item 1. Financial Statements
FAQ
- What is Altimmune's total current liabilities?
- Altimmune (ALT) reported total current liabilities of $11.32M in Q1 2026.
- How has Altimmune's total current liabilities changed year-over-year?
- Altimmune's total current liabilities increased by 15.6% year-over-year, from $9.8M to $11.32M.
- What is the long-term trend for Altimmune's total current liabilities?
- Over 5 years (2020 to 2025), Altimmune's total current liabilities has grown at a 4.5% compound annual growth rate (CAGR), from $12.02M to $15M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Altimmune's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude